NASO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 397
EU - Europa 102
AS - Asia 21
AF - Africa 6
SA - Sud America 3
Totale 529
Nazione #
US - Stati Uniti d'America 391
IT - Italia 49
FR - Francia 19
DE - Germania 11
CN - Cina 9
NL - Olanda 7
ZA - Sudafrica 6
CA - Canada 5
IN - India 5
FI - Finlandia 4
SE - Svezia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
HK - Hong Kong 2
BR - Brasile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
GB - Regno Unito 1
HU - Ungheria 1
LK - Sri Lanka 1
MX - Messico 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
TR - Turchia 1
UA - Ucraina 1
Totale 529
Città #
Fairfield 43
Santa Cruz 40
Ashburn 34
Rome 29
Buffalo 28
Woodbridge 21
Houston 20
Seattle 18
Cambridge 17
Wilmington 10
Chicago 7
Boardman 6
Los Angeles 6
Dallas 5
Des Moines 5
Helsinki 4
Milan 4
Muizenberg 4
San Diego 4
Ann Arbor 3
Fonte Nuova 3
Henderson 3
Las Vegas 3
Norma 3
Phoenix 3
Providence 3
Riva 3
Rostock 3
San Francisco 3
San Jose 3
Toronto 3
Zeist 3
's-Hertogenbosch 2
Andover 2
Chengdu 2
Chennai 2
Clearwater 2
Coimbatore 2
Dulles 2
Jinan 2
Naples 2
Ottawa 2
Paris 2
Pasadena 2
University Park 2
Utrecht 2
Wuhan 2
Aarhus 1
Atlanta 1
Auburn 1
Bergen 1
Bloomfield 1
Bremen 1
Brito 1
Brooklyn 1
Budapest 1
Cape Town 1
Ceprano 1
Chandler 1
Council Bluffs 1
Crugers 1
Essen 1
Ghedi 1
Hefei 1
Herndon 1
Hillsboro 1
Kowloon 1
Lake Forest 1
Lincoln 1
Lognes 1
Madrid 1
Mexico City 1
Milpitas 1
Monmouth Junction 1
Mountain View 1
New York 1
Nicosia 1
Nochchiyagama 1
Piscataway 1
Polska 1
Port Elizabeth 1
Pullach im Isartal 1
Randolph Township 1
Rio de Janeiro 1
Salem 1
San Mateo 1
Solna 1
Stockholm 1
Suzhou 1
Tortona 1
Totale 417
Nome #
PD-L1 expression in TNBC: a predictive biomarker of response to neoadjuvant chemotherapy?, file e383531a-00d1-15e8-e053-a505fe0a3de9 126
Relationship and predictive role of the dual expression of FGFR and IL-8 in metastatic renal cell carcinoma treated with targeted agents, file e3835322-645a-15e8-e053-a505fe0a3de9 122
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer. Pros and cons, file e3835323-43d5-15e8-e053-a505fe0a3de9 114
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in ER+/HERr2− patients: A propensity score-matched analysis of a multicenter retrospective patient series, file e383532c-501f-15e8-e053-a505fe0a3de9 46
Metastases to extraocular muscles from breast cancer: case report and up-to-date review of the literature, file e383531f-0b23-15e8-e053-a505fe0a3de9 42
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients, file e3835312-5af9-15e8-e053-a505fe0a3de9 28
Incidence and risk of pulmonary toxicity in patients treated with mTOR ihibitors for malignancy. A meta-analysis of published trials, file e3835311-b00b-15e8-e053-a505fe0a3de9 11
Circulating Tumor Cells in Cancer Therapy: Are we off Target?, file e3835311-d76b-15e8-e053-a505fe0a3de9 10
Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials, file e3835312-57c4-15e8-e053-a505fe0a3de9 10
The promise of liquid biopsy in cancer: a clinical perspective, file e3835321-a350-15e8-e053-a505fe0a3de9 10
A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer, file e3835311-6b6b-15e8-e053-a505fe0a3de9 6
How circulating tumor cells escape from multidrug resistance: translating molecular mechanisms in metastatic breast cancer treatment., file e3835312-23ec-15e8-e053-a505fe0a3de9 5
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients, file e3835311-7361-15e8-e053-a505fe0a3de9 4
Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization., file e3835311-d769-15e8-e053-a505fe0a3de9 4
Circulating tumor cells: highlight on practical implications., file e3835312-236e-15e8-e053-a505fe0a3de9 3
Circulating tumor cells lacking cytokeratin in breast cancer: the importance of being mesenchymal, file e3835311-caac-15e8-e053-a505fe0a3de9 2
Circulating tumor cells count and characterization in a male breast cancer patient, file e3835311-ea03-15e8-e053-a505fe0a3de9 2
Oncotype DX predictive nomogram for recurrence score output: the novel system ADAPTED01 based on quantitative immunochemistry analysis, file e383532e-1ed9-15e8-e053-a505fe0a3de9 2
T-DM1 Efficacy in patients with HER2-positive metastatic breast cancer progressing after a Taxane Plus Pertuzumab and Trastuzumab. An italian multicenter observational study, file e3835326-c696-15e8-e053-a505fe0a3de9 1
Totale 548
Categoria #
all - tutte 1.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.222


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 0 3 8 7
2019/2020113 5 3 1 10 14 13 14 14 16 7 10 6
2020/202174 10 7 3 4 6 5 5 6 11 3 4 10
2021/2022116 5 7 8 4 10 7 3 9 7 4 40 12
2022/2023173 6 9 45 24 10 32 13 9 11 6 8 0
2023/202447 1 1 3 1 15 11 4 7 3 1 0 0
Totale 548